These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16503123)

  • 41. Identification of mutations in Korean patients with amyotrophic lateral sclerosis using multigene panel testing.
    Kim HJ; Oh KW; Kwon MJ; Oh SI; Park JS; Kim YE; Choi BO; Lee S; Ki CS; Kim SH
    Neurobiol Aging; 2016 Jan; 37():209.e9-209.e16. PubMed ID: 26601740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Causative genes for familial amyotrophic lateral sclerosis].
    Hadano S
    Seikagaku; 2002 Jun; 74(6):483-9. PubMed ID: 12138710
    [No Abstract]   [Full Text] [Related]  

  • 43. Paradigms for the identification of new genes in motor neuron degeneration.
    Hafezparast M; Ahmad-Annuar A; Hummerich H; Shah P; Ford M; Baker C; Bowen S; Martin JE; Fisher EM
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Dec; 4(4):249-57. PubMed ID: 14753659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Cu/Zn superoxide dismutase gene in ALS and parkinsonism-dementia of Guam.
    Figlewicz DA; Garruto RM; Krizus A; Yanagihara R; Rouleau GA
    Neuroreport; 1994 Jan; 5(5):557-60. PubMed ID: 8025243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degeneration.
    Morrison BM; Morrison JH
    Brain Res Brain Res Rev; 1999 Jan; 29(1):121-35. PubMed ID: 9974153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modelling amyotrophic lateral sclerosis: progress and possibilities.
    Van Damme P; Robberecht W; Van Den Bosch L
    Dis Model Mech; 2017 May; 10(5):537-549. PubMed ID: 28468939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease.
    Bandmann O; Davis MB; Marsden CD; Harding AE
    J Neurol Neurosurg Psychiatry; 1995 Jul; 59(1):90-1. PubMed ID: 7608718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Exploration of pathogenesis-associated molecules and development of disease models for sporadic ALS].
    Tanaka F; Waza M; Niwa J; Yamamoto M; Sobue G
    Rinsho Shinkeigaku; 2008 Nov; 48(11):970-2. PubMed ID: 19198134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Amyotrophic lateral sclerosis associated with mutations in the SOD1 gene].
    Aoki M
    Rinsho Shinkeigaku; 2010 Nov; 50(11):861. PubMed ID: 21921473
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetics of sporadic ALS.
    Andersen PM
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S37-41. PubMed ID: 11465923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical implications of the genetics of ALS and other motor neuron diseases.
    Orrell RW; Figlewicz DA
    Neurology; 2001 Jul; 57(1):9-17. PubMed ID: 11460829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Molecular biology findings in amyotrophic lateral sclerosis].
    Bachus R; Claus A; Meyer T; Riepe M; Ludolph AC
    Nervenarzt; 1997 Oct; 68(10):785-91. PubMed ID: 9441250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The various forms of hereditary motor neuron disorders and their historical descriptions.
    Mathis S; Beauvais D; Duval F; Solé G; Le Masson G
    J Neurol; 2024 Jul; 271(7):3978-3990. PubMed ID: 38816479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Exploration of pathogenesis and therapy development for ALS employing sporadic disease model].
    Tanaka F; Waza M; Yamamoto M; Sobue G
    Rinsho Shinkeigaku; 2009 Nov; 49(11):811-3. PubMed ID: 20030217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies.
    Yamamoto M; Tanaka F; Tatsumi H; Sobue G
    Expert Opin Pharmacother; 2008 Aug; 9(11):1845-57. PubMed ID: 18627324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
    Andersen PM; Al-Chalabi A
    Nat Rev Neurol; 2011 Oct; 7(11):603-15. PubMed ID: 21989245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A specific superoxide dismutase mutation is on the same genetic background in sporadic and familial cases of amyotrophic lateral sclerosis.
    Hayward C; Swingler RJ; Simpson SA; Brock DJ
    Am J Hum Genet; 1996 Nov; 59(5):1165-7. PubMed ID: 8900247
    [No Abstract]   [Full Text] [Related]  

  • 58. Amyotrophic lateral sclerosis.
    Rowland LP; Shneider NA
    N Engl J Med; 2001 May; 344(22):1688-700. PubMed ID: 11386269
    [No Abstract]   [Full Text] [Related]  

  • 59. Next Generation Sequencing and ALS: known genes, different phenotyphes.
    Campopiano R; Ryskalin L; Giardina E; Zampatti S; Busceti CL; Biagioni F; Ferese R; Storto M; Gambardella S; Fornai F
    Arch Ital Biol; 2017 Dec; 155(4):110-117. PubMed ID: 29405028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exome sequencing uncovers hidden pathways in familial and sporadic ALS.
    Bettencourt C; Houlden H
    Nat Neurosci; 2015 May; 18(5):611-3. PubMed ID: 25919956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.